Satellos Bioscience MSLE
NASDAQ MSLE
$8.50 -0.01 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Cash & Equivalents (2023 - 2026)

Updated

Satellos Bioscience (MSLE) reported Cash & Equivalents of $7.39 million for the quarter ended Jun 30, 2026, down 60.5% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Cash & Equivalents (2023 - 2026) Analysis & Trends

As of Dec 31, 2024, Satellos Bioscience posted Cash & Equivalents of $40.07 million, up 140.2% from the prior year.

  • By year, Cash & Equivalents came in at $16.68 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Satellos Bioscience 131.40 Mn 131.40 Mn - 7.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.39 Mn
Mar 31, 2026 18.70 Mn
Dec 31, 2024 41.28 Mn
Dec 31, 2023 16.21 Mn
API Access

Satellos Bioscience Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MSLE&period=max&api_key=YOUR_API_KEY